Search results for " heart."

showing 10 items of 733 documents

Grip strength predicts cardiac adverse events in patients with cardiac disorders: an individual patient pooled meta-analysis.

2019

ObjectiveGrip strength is a well-characterised measure of weakness and of poor muscle performance, but there is a lack of consensus on its prognostic implications in terms of cardiac adverse events in patients with cardiac disorders.MethodsArticles were searched in PubMed, Cochrane Library, BioMed Central and EMBASE. The main inclusion criteria were patients with cardiac disorders (ischaemic heart disease, heart failure (HF), cardiomyopathies, valvulopathies, arrhythmias); evaluation of grip strength by handheld dynamometer; and relation between grip strength and outcomes. The endpoints of the study were cardiac death, all-cause mortality, hospital admission for HF, cerebrovascular accident…

medicine.medical_specialtyWeaknessMultivariate analysisHeart diseaseHeart Diseasesheart failure030204 cardiovascular system & hematologyCochrane LibraryHeart diseaseGlobal HealthNO03 medical and health sciencesGrip strength0302 clinical medicinePatient AdmissionInternal medicineCause of DeathHeart disease; heart failure; meta-analysis; Cardiology and Cardiovascular MedicinemedicineHumans030212 general & internal medicineMyocardial infarctionHand Strengthbusiness.industrymedicine.diseasePrognosishumanitiesSurvival Ratemeta-analysisCardiovascular System & HematologyMeta-analysisHeart failureCardiologymedicine.symptombusinessCardiology and Cardiovascular Medicine
researchProduct

Carotid ultrasound is useful for the cardiovascular risk stratification in patients with hidradenitis suppurativa.

2018

INTRODUCTION: Hidradenitis suppurativa (HS) is a chronic inflammatory cutaneous disease which has been associated with an increased risk of adverse cardiovascular (CV) outcomes. Adequate stratification of the CV risk is an issue of major importance in patients with HS. To analyze the usefulness of carotid ultrasound (US) assessment for the CV disease risk stratification compared with a traditional score, the Framingham risk score (FRS), in a series of patients with HS. METHODS: Cross-sectional study of 60 patients with HS without history of CV events, diabetes mellitus or chronic kidney disease. Information on CV risk factors was collected and the FRS was calculated. Thus, the patients were…

medicine.medical_specialtyanimal structuresCross-sectional studyEndocrine DisordersInflammatory DiseasesCardiologylcsh:MedicineBlood PressureDiseaseVascular MedicineBiochemistry030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes mellitusInternal medicineMedicine and Health SciencesDiabetes MellitusMedicineHumansCoronary Heart DiseaseIn patientHidradenitis suppurativalcsh:Science030203 arthritis & rheumatologyMultidisciplinaryFramingham Risk Scorebusiness.industrylcsh:RBiology and Life SciencesHealth Risk Analysismedicine.diseaseAtherosclerosisLipidsHidradenitis SuppurativaHealth CareBlood pressureCarotid ArteriesCross-Sectional StudiesCholesterolROC CurveCardiovascular DiseasesMetabolic Disorderslcsh:QbusinessKidney diseaseResearch ArticlePLoS ONE
researchProduct

Management of Atrial Fibrillation Suppression in AF-HF Comorbidity Therapy (MASCOT) Trial

2003

Inter- [1,2], intra- [3,4], and atrioventricular [51(AV) dyssynchrony are not new concepts, but only recently have attempts been made to correct these disorders in an effort to treat heart failure (HF). A series of trials [6] has addressed partial or comprehensive cardiac resynchronization in patients with severe HF and evidence of cardiac dyssynchrony. Cardiac resynchronization should improve left ventricular (LV) performance; several trials [7-10] have demonstrated improvement in many hemodynamic parameters (LV and aortic pressure, shortening of mitral diastolic regurgitation, synchronized LV and atrial systole, LV volume, reduced myocardial oxygen consumption) and clinical end-points (qu…

medicine.medical_specialtybusiness.industryDiastoleManagement of atrial fibrillationAtrial fibrillationmedicine.diseaseAsymptomaticFramingham Heart StudyHeart failureInternal medicineAortic pressurePhysical therapyCardiologyMedicinemedicine.symptomRisk factorbusiness
researchProduct

Épidémiologie du syndrome coronaire aigu en Europe

2007

Epidemiological data concerning acute coronary syndromes in Europe are based on national registries, studies by the European Society of Cardiology within the framework of the EuroHeart Survey and on the study of European population sub-groups in large international cohorts. In this article, recently published studies will be reviewed, and the principal developments in different countries as well as the characteristics and particularities of the most recent epidemiological data will be highlighted. In Europe, the presentation of acute coronary syndromes (ACS) has evolved considerably over the last ten years. This evolution is characterized by a reduction in the proportion of acute coronary s…

medicine.medical_specialtybusiness.industryEpidemiologymedicineMyocardial infarctionEuropean populationMyocardial diseaseCardiology and Cardiovascular MedicineIntensive care medicinemedicine.diseasebusinessCoronary heart diseaseAnnales de Cardiologie et d'Angéiologie
researchProduct

Letter by Sacha and Feusette Regarding Article, “Dynamic Edematous Response of the Human Heart to Myocardial Infarction: Implications for Assessing M…

2018

We have read with a great interest the article by Fernandez-Jimenez et al presenting a bimodal edematous reaction of reperfused myocardium after ST-segment elevation myocardial infarction (STEMI).1 According to the study, the initial edema emerges early and disappears by 24 hours; however, the second edema appears between days 4 and 7 after reperfusion. The authors conclude that the assessment of …

medicine.medical_specialtybusiness.industryHuman heart030204 cardiovascular system & hematologymedicine.diseaseArea at risk03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicineEdemamedicineCardiologycardiovascular diseases030212 general & internal medicineMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessCirculation
researchProduct

The Heart in Fabry Disease – from Pathogenesis to Enzyme Replacement Therapy

2010

The cardiovascular involvement in Fabry disease is progressive, and accounts for one of the major reasons for abbreviated life expectancy and increased morbidity. The majority of patients develop signs and symptoms, related to heart failure and arrhythmias. Hypertrophic cardiomyopathy, in later stages combined with myocardial fibrosis, is one of the leading features. Both genders are affected, and females develop severe cardiac Fabry disease approximately 10–15 years later in life than male patients. Diastolic dysfunction and reduced longitudinal mid-wall related systolic function are the mechanical consequences of the myocardial and epithelial changes related to accumulation of the storage…

medicine.medical_specialtybusiness.industryHypertrophic cardiomyopathyCardiomyopathyDiastoleEnzyme replacement therapyDiseasemedicine.diseaseFabry diseaseHeart failureInternal medicinemedicineCardiologyElectrical conduction system of the heartbusiness
researchProduct

Fetal programming as the cause of all the evils in adult humans: atherosclerosis and coronary heart disease included

2020

〈 Collection 2020/3 About us Imprint Open access Editorial board Contact Vision and mission Services Picture credits Disclaimer Congresses Job vacancies For readers Subscription Current issue Archives Search For authors Guidelines Copyright Submission Article types Supplements For advertisers Media data Portfolio Reader poll Reprints Offer Sales team Collection 2020/3 REVIEW ARTICLE Fetal programming as the cause of all the evils in adult humans: atherosclerosis and coronary heart disease included DOI: https://doi.org/10.4414/cvm.2020.02113 Publication Date: 11.06.2020 Cardiovasc Med. 2020;23:w02113 Balistreri Carmela R. Affiliationskeyboard_arrow_down Summary The theory of David Barker on …

medicine.medical_specialtybusiness.industryInternal medicinemedicineCardiologyFetal programmingCardiology and Cardiovascular Medicinebusinessdevelopmental programmingfetal cardiovas-cular developmentendothelial dysfunctionCoronary heart disease
researchProduct

Pulmonale Thrombendarteriektomie bei thromboembolischer pulmonaler Hypertonie: Indikationen und Frühergebnisse

2008

Pulmonary thrombendarterectomy was performed in 32 patients (14 men and 18 women; mean age 38 +/- 15 years) with thromboembolic pulmonary hypertension (New York Heart Association stage III: n = 22; stage IV: n = 10). The preoperative arterial pO2 averaged 59 +/- 11 mm Hg; pulmonary vascular resistance (PVR) and mean pressure (MPAP) were increased to 1,045 +/- 430 dyn.s.cm-5 and 53 +/- 12 mm Hg, respectively. The perioperative death rate was 22% (7 of 32). In the 25 survivors the pulmonary hypertension was reduced to a PVR of 194 +/- 75 dys.s.cm-5, MPAP of 28 +/- 6 mm Hg. Subsequent re-examination in 15 patients (NYHA stage I: n = 14, stage II: n = 1) after a mean of 17 +/- 5 months demonstr…

medicine.medical_specialtybusiness.industryMean pressureGeneral MedicineStage iimedicine.diseasePulmonary hypertensionNew york heart associationmedicine.anatomical_structureEarly resultsInternal medicineVascular resistancemedicineCardiologyStage (cooking)businessThromboembolic pulmonary hypertensionDMW - Deutsche Medizinische Wochenschrift
researchProduct

Dominant frequency and complexity of electrical reentrant activation during ventricular fibrillation with releasing of NO after acute local stretchin…

2013

medicine.medical_specialtybusiness.industryRabbit heartCardiac arrhythmiaDominant frequencymedicine.diseaseReentrancyInternal medicineVentricular fibrillationCardiologymedicineMyocyteCardiology and Cardiovascular MedicinebusinessPerfusionInotropic agentEuropean Heart Journal
researchProduct

Effects of exercise training on oxygen uptake in coronary heart disease: a systematic review and meta-analysis

2010

It is not known to what extent exercise programs increase maximal oxygen uptake (VO(2max)) in patients with coronary heart diseases (CHD). The purpose of this study is to determine the effect of exercise interventions on VO(2max) in subjects with CHD. Database search of randomized controlled trials was conducted from PubMed. Studies were included that reported the characteristics and effects of exercise interventions in subjects with CHD, included a non-exercise control group and measured VO(2max) using direct measurement method. Eighteen studies were eligible. Exercise interventions increased VO(2max) by 2.6 +/- 1.6 and 0.3 +/- 1.4 mL/kg/min in the training and control groups, respectively…

medicine.medical_specialtybusiness.industryVO2 maxPhysical Therapy Sports Therapy and RehabilitationOxygen uptakeCoronary heart diseaselaw.inventionRandomized controlled triallawStrictly standardized mean differenceMeta-analysisPhysical therapymedicineAerobic exerciseOrthopedics and Sports MedicinebusinessTraining periodScandinavian Journal of Medicine & Science in Sports
researchProduct